- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/16 - OxytocinsVasopressinsRelated peptides
Patent holdings for IPC class C07K 7/16
Total number of patents in this class: 111
10-year publication summary
6
|
10
|
6
|
9
|
9
|
5
|
6
|
10
|
7
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Ferring B.V. | 705 |
17 |
Hybio Pharmaceutical Co., Ltd. | 121 |
8 |
Trigemina, Inc. | 9 |
6 |
Hoffmann-La Roche Inc. | 3454 |
5 |
PharmaIN Corporation | 36 |
5 |
F. Hoffmann-La Roche AG | 7939 |
4 |
The Board of Trustees of the Leland Stanford Junior University | 6441 |
4 |
B.r.a.h.m.s GmbH | 176 |
4 |
Ocelot bio, Inc. | 6 |
3 |
The General Hospital Corporation | 4751 |
2 |
Aarhus Universitet | 422 |
2 |
Bachem Holding AG | 40 |
2 |
HealthPartners Research & Education | 19 |
2 |
Monash University | 710 |
2 |
National University Corporation Hokkaido University | 1344 |
2 |
Sichuan University | 570 |
2 |
Tulex Pharmaceuticals Inc., DBA Tulex Pharmaceuticals Inc. | 19 |
2 |
The Board of Regents of the University of Texas System | 2214 |
2 |
River 2 Renal Corp. | 3 |
2 |
Northwestern University | 3403 |
1 |
Other owners | 34 |